Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%.

@article{Collins2001DeathHA,
  title={Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%.},
  author={Allan J. Collins and Shuling Li and Wendy L St. Peter and Jim Ebben and Tricia L Roberts and Jennie Z Ma and Willard Manning},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2001},
  volume={12 11},
  pages={2465-73}
}
Anemia treatment with epoetin has led to dramatic increases in hematocrit levels since 1989. Studies have demonstrated that morbidity and mortality rates are lower when hematocrit values are within the Disease Outcomes Quality Initiative (DOQI) target range (33 to 36%). Recently, clinical studies demonstrated that patients without cardiovascular disease exhibited lower morbidity rates and improved cognitive function with hematocrit values of >36%. One prospective trial, in contrast… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 109 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Clinical Practice Guidelines: Final Guideline Summaries from the Work Groups of the National Kidney Foundation-Dialysis Outcomes Quality Initiative, New York

  • G Eknoyan, N Levin
  • National Kidney Foundation,
  • 1997

Similar Papers

Loading similar papers…